Ingredients group Tate & Lyle has signed an agreement to acquire Quantum Hi-Tech (Guangdong) Biological Co., Ltd (Quantum), a prebiotic dietary fibre business in China from ChemPartner Pharmatech Co., Ltd (ChemPartner) for a total consideration of $237 million (€214 million).
Quantum engages in the research, development, production, and sale of fructo-oligosaccharides (FOS) and galacto-oligosaccharides (GOS).
Together, FOS (from sucrose) and GOS (from milk sugar/lactose) represent around 25% of the global dietary fibres market which is forecast to grow at around 6% per annum.
In China, which currently represents the majority of Quantum’s sales, the FOS and GOS market is forecast to grow at around 10% per annum.
Details Of Tate & Lyle Acquisition
Tate & Lyle believes that the acquisition of Quantum will 'significantly strengthen' its position in dietary fibres, adding to its portfolio of speciality fibres, R&D capabilities, and proprietary manufacturing processes and technologies.
The deal will boost Tate & Lyle’s ability to provide added-fibre solutions for its customers across a range of categories including dairy, beverages, bakery, and nutrition (including infant nutrition), and meet growing consumer interest in gut health.
It also expands Tate & Lyle’s presence in China and Asia, and extends its capabilities to create solutions across food and drink utilising its speciality ingredient portfolio.
The transaction is subject to approval by the shareholders of ChemPartner, a public company listed in China, of which Quantum is a wholly-owned subsidiary.
At completion, consideration will be paid in cash for 100% of the equity interests in Quantum, Tate & Lyle noted.
For the 11 months ended 30 November 2021, Quantum generated revenue of US$46 million (€42 million) and EBITDA of US$14 million (€13 million).
The acquisition is expected to be accretive to revenue growth and EBITDA margin for Tate & Lyle in the first year of ownership.
Quantum produces its range of FOS and GOS fibres at its production site in Guangdong Province, Southern China.
The management team of Quantum will join Tate & Lyle at completion.
The transaction is expected to close in the second quarter of the 2022 calendar year.
Nick Hampton, chief executive at Tate & Lyle, said, "We are delighted to announce the agreement to acquire Quantum, a leader in prebiotic dietary fibres and a business recognised for its high-quality ingredients and solutions. This acquisition significantly strengthens our fortification capabilities and expands our customer offering in key food and drink categories."
"The acquisition is also very much in line with our purpose to support healthy living by improving gut health, and driving sugar and calorie reduction and fibre fortification for consumers across the world," he added. [Photo Courtesy: Nayeli Reyes Cuentos Culinarios]